Fwd: RESIST-TB Webinar Series - 2017-2018 DR-TB Working Group Survey Results

By Erica Lessem | 05 Jun, 2018


---------- Forwarded message ----------
From: RESIST-TB <>
Date: Mon, Jun 4, 2018 at 5:10 PM
Subject: RESIST-TB Webinar Series - 2017-2018 DR-TB Working Group Survey

Presentation: Webinar on the 2017-2018 DR-TB Working Group Survey Results
*View this email in your browser


The Union and RESIST-TB invite you to join an exciting webinar on *Thursday,
June 7th from 08:00 - 09:00 EST (14:00 - 15:00 CET and SAST)* for the first
release of the results of the 2018 global survey of the rollout of
bedaquiline, delamanid and the 9-month regimen for MDR-TB. We will estimate
the current status of each of these, as well as identify progress in
comparison to the 2017 survey. This presentation will be followed by a
discussion focusing on barriers to roll-out identified by the survey
respondents. Webinar participants will be able to make comments and ask
questions of the moderators and other participants.

Please read the below information on how to register to receive connection
details for this webinar.
*To join the event as an attendee*
1. Go to https://attendee.gotowebinar.com/register/5471390152498883843
2. Fill out the required fields and click the "Register" button at the
bottom of the page.

*NOTE: If you are member of the Union, please enter your CU- membership ID
in the designated field. If you are NOT a member of the Union, please leave
this field blank. *

After you have registered for the event, you will receive a follow-up email
from the Union with the link and instructions to join the webinar.

For assistance
To contact your host, RESIST-TB, please send a message to

IMPORTANT NOTICE: This WebEx service includes a feature that allows audio
and any documents and other materials exchanged or viewed during the
session to be recorded. By joining this session, you automatically consent
to such recordings. If you do not consent to the recording, discuss your
concerns with the meeting host prior to the start of the recording or do
not join the session. Please note that any such recordings may be subject
to discovery in the event of litigation.
RESIST-TB is a movement to promote and conduct research on the treatment
and prevention of drug-resistant tuberculosis, with a commitment to address
the substantial existing gaps in our knowledge and to help provide access
to an effective cure and prophylaxis of drug-resistant tuberculosis
throughout the world.

To find out more about RESIST-TB’s work as well as the latest news and
publications on MDR-TB, please visit our website at www.resisttb.org
[image: Twitter]
[image: Email] <>
[image: Website]